166 related articles for article (PubMed ID: 7191706)
21. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
Sariban E; Erickson LC; Kohn KW
Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
[TBL] [Abstract][Full Text] [Related]
22. Hydroxylation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Hilton J; Walker MD
Biochem Pharmacol; 1975 Dec; 24(23):2153-8. PubMed ID: 1212264
[No Abstract] [Full Text] [Related]
23. Active site specific inactivation of chymotrypsin by cyclohexyl isocyanate formed during degradation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Babson JR; Reed DJ; Sinkey MA
Biochemistry; 1977 Apr; 16(8):1584-9. PubMed ID: 856251
[TBL] [Abstract][Full Text] [Related]
24. The binding of 14C labelled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) to macromolecules of sensitive and resistant tumours.
Connors TA; Hare JR
Br J Cancer; 1974 Nov; 30(5):477-80. PubMed ID: 4469198
[No Abstract] [Full Text] [Related]
25. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
[TBL] [Abstract][Full Text] [Related]
26. Nitrosourea pharmacodynamics in relation to the central nervous system.
Walker MD; Hilton J
Cancer Treat Rep; 1976 Jun; 60(6):725-8. PubMed ID: 954011
[No Abstract] [Full Text] [Related]
27. Mechanism of action of the nitrosoureas: formation of 1,2-(diguanosin-7-yl) ethane from the reaction of BCNU (1,3-bis-[2-chloroethyl]-1-nitrosourea) with guanosine.
Gombar CT; Tong WP; Ludlum DB
Biochem Biophys Res Commun; 1979 Oct; 90(3):878-82. PubMed ID: 508350
[No Abstract] [Full Text] [Related]
28. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():137-49. PubMed ID: 6944256
[No Abstract] [Full Text] [Related]
29. Stereoselective monooxygenation of carcinostatic 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by purified cytochrome P-450 isozymes.
Potter DW; Levin W; Ryan DE; Thomas PE; Reed DJ
Biochem Pharmacol; 1984 Feb; 33(4):609-13. PubMed ID: 6704177
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of 1,3-bis(2-chloroethyl)-1-nitrosourea by rat hepatic microsomes.
Lin HS; Weinkam RJ
J Med Chem; 1981 Jun; 24(6):761-3. PubMed ID: 7252986
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of positron-labeled 1,3-bis(2-chloroethyl)nitrosourea in human brain tumors using positron emission tomography.
Diksic M; Sako K; Feindel W; Kato A; Yamamoto YL; Farrokhzad S; Thompson C
Cancer Res; 1984 Jul; 44(7):3120-4. PubMed ID: 6609769
[TBL] [Abstract][Full Text] [Related]
32. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
August EM; Prusoff WH
Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823
[TBL] [Abstract][Full Text] [Related]
33. Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.
Brajtburg J; Elberg S; Kobayashi GS; Medoff G
Antimicrob Agents Chemother; 1988 Mar; 32(3):327-30. PubMed ID: 3284460
[TBL] [Abstract][Full Text] [Related]
34. Modification of proteins by 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (nsc 79037) in vitro.
Schmall B; Cheng CJ; Fujimura S; Gersten N; Grunberger D; Weinstein IB
Cancer Res; 1973 Aug; 33(8):1921-4. PubMed ID: 4578566
[No Abstract] [Full Text] [Related]
35. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.
Baril BB; Baril EF; Laszlo J; Wheeler GP
Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855
[TBL] [Abstract][Full Text] [Related]
36. Mutagenicity of nitrosourea compounds for Salmonella typhimurium.
Auletta AE; Martz AG; Parmar AS
J Natl Cancer Inst; 1978 Jun; 60(6):1495-7. PubMed ID: 349171
[TBL] [Abstract][Full Text] [Related]
37. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
[TBL] [Abstract][Full Text] [Related]
38. 2-chloroethanol formation as evidence for a 2-chloroethyl alkylating intermediate during chemical degradation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
Reed DJ; May HE; Boose RB; Gregory KM; Beilstein MA
Cancer Res; 1975 Mar; 35(3):568-76. PubMed ID: 1116123
[TBL] [Abstract][Full Text] [Related]
39. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
40. Microsomal monooxygenation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Synthesis and identification of cis and trans monohydroxylated products.
May HE; Boose R; Reed DJ
Biochemistry; 1975 Oct; 14(21):4723-30. PubMed ID: 1182112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
